Publication:
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

dc.contributor.authorBorrero-Palacios, A
dc.contributor.authorCebrián, A
dc.contributor.authorGómez Del Pulgar, M T
dc.contributor.authorGarcía-Carbonero, R
dc.contributor.authorGarcia-Alfonso, P
dc.contributor.authorAranda, E
dc.contributor.authorElez, E
dc.contributor.authorLópez-López, R
dc.contributor.authorCervantes, A
dc.contributor.authorValladares, M
dc.contributor.authorNadal, C
dc.contributor.authorViéitez, J M
dc.contributor.authorGuillén-Ponce, C
dc.contributor.authorRodríguez, J
dc.contributor.authorHernández, I
dc.contributor.authorGarcía, J L
dc.contributor.authorVega-Bravo, R
dc.contributor.authorPuime-Otin, A
dc.contributor.authorMartínez-Useros, J
dc.contributor.authorDel Puerto-Nevado, L
dc.contributor.authorRincón, R
dc.contributor.authorRodríguez-Remírez, M
dc.contributor.authorRojo, F
dc.contributor.authorGarcía-Foncillas, J
dc.date.accessioned2023-01-25T13:33:35Z
dc.date.available2023-01-25T13:33:35Z
dc.date.issued2019-05-17
dc.description.abstractA correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
dc.identifier.doi10.1038/s41598-019-43809-z
dc.identifier.essn2045-2322
dc.identifier.pmcPMC6522500
dc.identifier.pmid31097738
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522500/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41598-019-43809-z.pdf
dc.identifier.urihttp://hdl.handle.net/10668/13974
dc.issue.number1
dc.journal.titleScientific reports
dc.journal.titleabbreviationSci Rep
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number7706
dc.pubmedtypePublished Erratum
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleAuthor Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6522500.pdf
Size:
699.75 KB
Format:
Adobe Portable Document Format